MESO Stock Summary and Trading Ideas (Mesoblast Limited - American Depositary Shares | NASDAQ:MESO)

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Mesoblast Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol MESO.

As of August 20, 2026, MESO stock price climbed to $17.43 with 263,734 million shares trading.

MESO has a beta of 1.92, meaning it tends to be more sensitive to market movements. MESO has a correlation of 0.18 to the broad based SPY ETF.

MESO has a market cap of $2.26 billion. This is considered a Mid Cap stock.

Last quarter Mesoblast Limited - American Depositary Shares reported $51 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.17.

In the last 3 years, MESO traded as high as $22.00 and as low as $1.61.

The top ETF exchange traded funds that MESO belongs to (by Net Assets): IBB, APIE, QQQS, IBBQ, BIB.

MESO has underperformed the market in the last year with a return of +15.1%, while SPY returned +20.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MESO shares. However, MESO has outperformed the market in the last 3 month and 2 week periods, returning +19.8% and +16.5%, while SPY returned +4.2% and -0.9%, respectively. This indicates MESO has been having a stronger performance recently.

MESO support price is $16.58 and resistance is $17.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MESO shares will trade within this expected range on the day.